Lipid peroxidation and myocardial vulnerability in hypertrophied SHR myocardium
- 31 August 1992
- journal article
- research article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 57 (1), 29-38
- https://doi.org/10.1016/0014-4800(92)90046-e
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- NADPH- and adriamycin-dependent microsomal release of iron and lipid peroxidationArchives of Biochemistry and Biophysics, 1990
- Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicityPharmacology & Therapeutics, 1990
- Subcellular effects of adriamycin in the heart: A concise reviewJournal of Molecular and Cellular Cardiology, 1987
- Utilization of SHR in the detection of cardiotoxicityJapanese Heart Journal, 1987
- Application of the thiobarbiturate assay to the measurement of lipid peroxidation products in microsomesJournal of Biochemical and Biophysical Methods, 1986
- Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive ratsToxicology and Applied Pharmacology, 1985
- Doxorubicin Cardiotoxicity in the RatJournal of Cardiovascular Pharmacology, 1984
- An electrogenic Na+/Ca2+ antiporter in addition to the Ca2+ pump in cardiac sarcolemmaBiochimica et Biophysica Acta (BBA) - Biomembranes, 1981
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Quantitative determination of tocopherols by high-speed liquid chromatography.Journal of Nutritional Science and Vitaminology, 1975